Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore

Nucleus

Volumn 1, Issue 4, 2010, Pages 299-308

  Galigniana, Mario D ^a,b   Echeverría, Pablo C ^c   Erlejman, Alejandra G ^a   Piwien Pilipuk, Graciela ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Dynein; Heat shock proteins; Immunophilins; Importins; Nucleoporins; Shuttling

Indexed keywords

CHAPERONE; CYCLOPHILIN; DYNACTIN; FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KARYOPHERIN BETA; MINERALOCORTICOID RECEPTOR; NUCLEOPORIN; PROTEIN NUP62; PROTEIN P23; SERINE THREONINE PROTEIN PHOSPHATASE 5; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS MEMBRANE; LIGAND BINDING; NUCLEAR PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 78651320914     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.1.4.11743     Document Type: Article

References (77)

1. Aridor M, Hannan LA. Traffic jams II: an update of diseases of intracellular transport. Traffic 2002; 3:781-90.
2. Cobbold C, Monaco AP, Sivaprasadarao A, Ponnambalam S. Aberrant trafficking of transmembrane proteins in human disease. Trends Cell Biol 2003; 13:639-47.
3. Fabbro M, Henderson BR. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 2003; 282:59-69.
4. Perry RB, Fainzilber M. Nuclear transport factors in neuronal function. Semin Cell Dev Biol 2009; 20:600-6.
5. DeFranco DB. Navigating steroid hormone receptors through the nuclear compartment. Mol Endocrinol 2002; 16:1449-55.
6. Vicent GP, Pecci A, Ghini A, Piwien-Pilipuk G, Galigniana MD. Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses. Exp Cell Res 2002; 276:142-54.
7. Xu L, Massague J. Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol 2004; 5:209-19.
8. Seksek O, Biwersi J, Verkman AS. Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus. J Cell Biol 1997; 138:131-42.
9. Ambron RT, Schmied R, Huang CC, Smedman M. A signal sequence mediates the retrograde transport of proteins from the axon periphery to the cell body and then into the nucleus. J Neurosci 1992; 12:2813-8.
10. Medalia O, Weber I, Frangakis AS, Nicastro D, Gerisch G, Baumeister W. Macromolecular architecture in eukaryotic cells visualized by cryoelectron tomography. Science 2002; 298:1209-13.
11. Galigniana MD, Harrell JM, Housley PR, Patterson C, Fisher SK, Pratt WB. Retrograde transport of the glucocorticoid receptor in neurites requires dynamic assembly of complexes with the protein chaperone hsp90 and is linked to the CHIP component of the machinery for proteasomal degradation. Brain Res Mol Brain Res 2004; 123:27-36.
12. Jiang J, Cyr D, Babbitt RW, Sessa WC, Patterson C. Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. J Biol Chem 2003; 278:49332-41.
13. Piwien Pilipuk G, Galigniana MD. Subcellular movement of signalling molecules. How and why? in Leeds DT, (ed): Focus on Cellular Signalling. New York: Nova Publishers 2006; 73-107.
14. Galigniana MD, Radanyi C, Renoir JM, Housley PR, Pratt WB. Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J Biol Chem 2001; 276:14884-9.
15. Grad I, Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 2007; 275:2-12.
16. Smith DF, Toft DO. Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol 2008; 22:2229-40.
17. Jackson SE, Queitsch C, Toft D. Hsp90: from structure to phenotype. Nat Struct Mol Biol 2004; 11:1152-5.
18. Wandinger SK, Richter K, Buchner J. The Hsp90 chaperone machinery. J Biol Chem 2008; 283:18473-7.
19. Pratt WB, Galigniana MD, Morishima Y, Murphy PJ. Role of molecular chaperones in steroid receptor action. Essays Biochem 2004; 40:41-58.
20. McKeen HD, McAlpine K, Valentine A, Quinn DJ, McClelland K, Byrne C, et al. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology 2008; 149:5724-34.
21. Pratt WB, Galigniana MD, Harrell JM, DeFranco DB. Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 2004; 16:857-72.
22. Smith DF, Schowalter DB, Kost SL, Toft DO. Reconstitution of progesterone receptor with heat shock proteins. Mol Endocrinol 1990; 4:1704-11.
23. Hutchison KA, Brott BK, De Leon JH, Perdew GH, Jove R, Pratt WB. Reconstitution of the multiprotein complex of pp60src, hsp90 and p50 in a cell-free system. J Biol Chem 1992; 267:2902-8.
24. Stancato LF, Chow YH, Hutchison KA, Perdew GH, Jove R, Pratt WB. Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system. J Biol Chem 1993; 268:21711-6.
25. Dittmar KD, Banach M, Galigniana MD, Pratt WB. The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex. J Biol Chem 1998; 273:7358-66.
26. Pratt WB, Silverstein AM, Galigniana MD. A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37. Cell Signal 1999; 11:839-51.
27. Morishima Y, Kanelakis KC, Murphy PJ, Lowe ER, Jenkins GJ, Osawa Y, et al. The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein: hsp90 complex. J Biol Chem 2003; 278:48754-63.
28. Picard D. Intracellular dynamics of the Hsp90 cochaperone p23 is dictated by Hsp90. Exp Cell Res 2006; 312:198-204.
29. Picard D, Suslova E, Briand PA. 2-color photobleaching experiments reveal distinct intracellular dynamics of two components of the Hsp90 complex. Exp Cell Res 2006; 312:3949-58.
30. Thomas M, Harrell JM, Morishima Y, Peng HM, Pratt WB, Lieberman AP. Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum Mol Genet 2006; 15:1876-83.
31. Toft DO. Recent Advances in the Study of hsp90 Structure and Mechanism of Action. Trends Endocrinol Metab 1998; 9:238-43.
32. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996; 381:571-9.
33. Kanelakis KC, Shewach DS, Pratt WB. Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor. hsp90 heterocomplex assembly. J Biol Chem 2002; 277:33698-703.
34. Smith DF, Sullivan WP, Marion TN, Zaitsu K, Madden B, McCormick DJ, Toft DO. Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol Cell Biol 1993; 13:869-76.
35. Kanelakis KC, Morishima Y, Dittmar KD, Galigniana MD, Takayama S, Reed JC, et al. Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery. J Biol Chem 1999; 274:34134-40.
36. Young JC, Obermann WM, Hartl FU. Specific binding of tetratricopeptide repeat proteins to the C-terminal 12-kDa domain of hsp90. J Biol Chem 1998; 273:18007-10.
37. Silverstein AM, Galigniana MD, Kanelakis KC, Radanyi C, Renoir JM, Pratt WB. Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90 and cytoplasmic dynein. J Biol Chem 1999; 274:36980-6.
38. Gallo LI, Ghini AA, Pilipuk GP, Galigniana MD. Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity. Biochemistry 2007; 46:14044-57.
39. Galigniana MD, Harrell JM, Murphy PJ, Chinkers M, Radanyi C, Renoir JM, et al. Binding of hsp90associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry 2002; 41:13602-10.
40. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 2005; 280:4609-16.
41. Davies TH, Ning YM, Sanchez ER. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 2005; 44:2030-8.
42. Witchel SF, DeFranco DB. Mechanisms of disease: regulation of glucocorticoid and receptor levels- impact on the metabolic syndrome. Nat Clin Pract Endocrinol Metab 2006; 2:621-31.
43. Galigniana MD, Piwien Pilipuk G. Activation of the ligand-mineralocorticoid receptor functional unit by ancient, classical and novel ligands. Structureactivity relationship. Vitam Horm 2004; 69:31-68.
44. Davies TH, Ning YM, Sanchez ER. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 2002; 277:4597-600.
45. Galigniana MD. Functional regulation of corticosteroid receptors by phosphorylation and redox potential. Current Topics in Steroid Research 2000; 3:1-22.
46. Galigniana MD, Piwien Pilipuk G, Kanelakis KC, Burton G, Lantos CP. Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnanesteroids. Mol Cell Endocrinol 2004; 217:167-79.
47. Galigniana MD, Harrell JM, O'Hagen HM, Ljungman M, Pratt WB. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J Biol Chem 2004; 279:22483-9.
48. Galigniana MD, Erlejman AG, Monte M, GomezSanchez C, Piwien-Pilipuk G. The hsp90-FKBP52 Complex Links the Mineralocorticoid Receptor to Motor Proteins and Persists Bound to the Receptor in Early Nuclear Events. Mol Cell Biol 2010; 30:1285-98.
49. Kardon JR, Vale RD. Regulators of the cytoplasmic dynein motor. Nat Rev Mol Cell Biol 2009; 10:854-65.
50. Harrell JM, Murphy PJ, Morishima Y, Chen H, Mansfield JF, Galigniana MD, et al. Evidence for glucocorticoid receptor transport on microtubules by dynein. J Biol Chem 2004; 279:54647-54.
51. Elad N, Maimon T, Frenkiel-Krispin D, Lim RY, Medalia O. Structural analysis of the nuclear pore complex by integrated approaches. Curr Opin Struct Biol 2009; 19:226-32.
52. Lusk CP, Blobel G, King MC. Highway to the inner nuclear membrane: rules for the road. Nat Rev Mol Cell Biol 2007; 8:414-20.
53. Terry LJ, Shows EB, Wente SR. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 2007; 318:1412-6.
54. Stewart M. Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 2007; 8:195-208.
55. Fagotto F, Gluck U, Gumbiner BM. Nuclear localization signal-independent and importin/karyopherinindependent nuclear import of beta-catenin. Curr Biol 1998; 8:181-90.
56. Picard D, Yamamoto KR. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 1987; 6:3333-40.
57. Walther RF, Atlas E, Carrigan A, Rouleau Y, Edgecombe A, Visentin L, et al. A serine/threoninerich motif is one of three nuclear localization signals that determine unidirectional transport of the mineralocorticoid receptor to the nucleus. J Biol Chem 2005; 280:17549-61.
58. Piwien Pilipuk G, Vinson GP, Sanchez CG, Galigniana MD. Evidence for NL1-Independent Nuclear Translocation of the Mineralocorticoid Receptor. Biochemistry 2007; 46:1389-97.
59. Passinen S, Valkila J, Manninen T, Syvala H, Ylikomi T. The C-terminal half of Hsp90 is responsible for its cytoplasmic localization. Eur J Biochem 2001; 268:5337-42.
60. Kang KI, Devin J, Cadepond F, Jibard N, Guiochon- Mantel A, Baulieu EE, et al. In vivo functional protein-protein interaction: nuclear targeted hsp90 shifts cytoplasmic steroid receptor mutants into the nucleus. Proc Natl Acad Sci USA 1994; 91:340-4.
61. Echeverria PC, Mazaira G, Erlejman A, Gomez-Sanchez C, Piwien Pilipuk G, Galigniana MD. Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta. Mol Cell Biol 2009; 29:4788-97.
62. Sanchez ER, Hirst M, Scherrer LC, Tang HY, Welsh MJ, Harmon JM, et al. Hormone-free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90. J Biol Chem 1990; 265:20123-30.
63. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ, et al. Discrimination between NL1and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 1999; 19:1025-37.
64. Li H, Fidler ML, Lim CS. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity. Mol Pharm 2005; 2:509-18.
65. Freedman ND, Yamamoto KR. Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell 2004; 15:2276-86.
66. Tanaka M, Nishi M, Morimoto M, Sugimoto T, Kawata M. Yellow fluorescent protein-tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins in single living cells. Endocrinology 2003; 144:4070-9.
67. Hodel AE, Harreman MT, Pulliam KF, Harben ME, Holmes JS, Hodel MR, et al. Nuclear localization signal receptor affinity correlates with in vivo localization in Saccharomyces cerevisiae. J Biol Chem 2006; 281:23545-56.
68. Gilchrist D, Mykytka B, Rexach M. Accelerating the rate of disassembly of karyopherin.cargo complexes. J Biol Chem 2002; 277:18161-72.
69. Jakel S, Mingot JM, Schwarzmaier P, Hartmann E, Gorlich D. Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains. EMBO J 2002; 21:377-86.
70. Georget V, Terouanne B, Nicolas JC, Sultan C. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry 2002; 41:11824-31.
71. Denning DP, Patel SS, Uversky V, Fink AL, Rexach M. Disorder in the nuclear pore complex: the FG repeat regions of nucleoporins are natively unfolded. Proc Natl Acad Sci USA 2003; 100:2450-5.
72. Patel SS, Belmont BJ, Sante JM, Rexach MF. Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex. Cell 2007; 129:83-96.
73. Murphy PJ, Morishima Y, Chen H, Galigniana MD, Mansfield JF, Simons SS Jr, et al. Visualization and mechanism of assembly of a glucocorticoid receptor. Hsp70 complex that is primed for subsequent Hsp90dependent opening of the steroid binding cleft. J Biol Chem 2003; 278:34764-73.
74. Pemberton LF, Rosenblum JS, Blobel G. Nuclear import of the TATA-binding protein mediation by the karyopherin Kap114p and a possible mechanism for intranuclear targeting. J Cell Biol 1999; 145:1407-17.
75. Kose S, Furuta M, Koike M, Yoneda Y, Imamoto N. The 70-kD heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors. J Cell Biol 2005; 171:19-25.
76. Guerrero-Santoro J, Yang L, Stallcup MR, DeFranco DB. Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. J Cell Biochem 2004; 92:810-9.
77. Tago K, Tsukahara F, Naruse M, Yoshioka T, Takano K. Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90. Mol Cell Endocrinol 2004; 213:131-8.